Abeona Therapeutics
ABEO
$4.24
Share price
-4.83%
Change (1 day)
33.18%
Change (1 year)
Categories
P/S ratio for Abeona Therapeutics (ABEO)
P/S ratio as of May 2024 (TTM): 48.4
According to Abeona Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 48.435. At the end of 2023 the company had a P/S ratio of 35.5.
P/S ratio history for Abeona Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 35.5 | -5.22% |
| 2022 | 37.4 | 127.16% |
| 2021 | 16.5 | 6.47% |
| 2020 | 15.5 | |
| 2019 | N/A | -100% |
| 2018 | 882 | -0.39% |
| 2017 | 886 | 306.31% |
| 2016 | 218 | 106.08% |
| 2015 | 106 | 42.09% |
| 2014 | 74.4 | 2263.44% |
| 2013 | 3.15 | 133.71% |
| 2012 | 1.35 | -92.54% |
| 2011 | 18.1 | -81.67% |
| 2010 | 98.6 | -19.94% |
| 2009 | 123 | 108.26% |
| 2008 | 59.1 | 176.25% |
| 2007 | 21.4 | |
| 2005 | 15.1 | -84.92% |
| 2004 | 100 | 85.25% |
| 2003 | 54.0 | 213.91% |
| 2002 | 17.2 | -92.68% |
| 2001 | 235 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merck MRK | 5.49 | -88.66% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | 2.60 | -94.63% | 🇮🇱 Israel |